insights_auto
为什么 AGIO 下跌了 4.03%?
深入探索chevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$27.60
arrow_downward
-4.03%(-1.16) 1 天
US$27.60
0.00% (0.00)
bedtime盘后交易
休市: 11月20日, GMT-5 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AGIO 生成关键数据洞见…
开盘价
US$28.01
最高价
US$29.14
最低价
US$27.43
市值
16.51亿
平均成交量
112.76万
成交量
77.62万
52 周最高价
US$44.07
52 周最低价
US$23.02
每股收益
-US$6.32
Beta 版
0.66
流通股数
5981.00万
员工人数
540
开盘价
US$28.01
最高价
US$29.14
最低价
US$27.43
市值
16.51亿
平均成交量
112.76万
成交量
77.62万
52 周最高价
US$44.07
52 周最低价
US$23.02
每股收益
-US$6.32
Beta 版
0.66
流通股数
5981.00万
员工人数
540
新闻报道
来自网络来源和新闻合作伙伴
The Arkansas Democrat-Gazette
·
1小时前
AI-led sell-off drags S&P 500 down by 3.7%
Traders Union
·
4小时前
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
·
1小时前
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
Trefis
·
2小时前
25 S&P 500 Stocks Just Made New 52-Week Lows
资料
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Agios Pharmaceuticals Inc简介